139 related articles for article (PubMed ID: 33160727)
1. Immune-mediated necrotizing myopathy after treatment with adalimumab in a patient with HLA-B27 ankylosing spondylitis.
Chavarría-Miranda A; Hernández Lain A; Toldos González O; Pedraza Hueso MI
Neurologia (Engl Ed); 2020 Nov; ():. PubMed ID: 33160727
[No Abstract] [Full Text] [Related]
2. Immune-mediated necrotising myopathy after treatment with adalimumab in a patient with HLA-B27 ankylosing spondylitis.
Chavarría-Miranda A; Hernández Lain A; Toldos González O; Pedraza Hueso MI
Neurologia (Engl Ed); 2021 Oct; 36(8):631-632. PubMed ID: 34238714
[No Abstract] [Full Text] [Related]
3. Multiple sclerosis during adalimumab treatment in a case with ankylosing spondylitis.
Uygunoğlu U; Uluduz D; Taşçılar K; Saip S
Rheumatol Int; 2014 Jan; 34(1):141-3. PubMed ID: 23269571
[TBL] [Abstract][Full Text] [Related]
4. Usage of Conventional PCR Technology for the Detection of HLA-B27 Allele: A Significant Molecular Marker of Ankylosing Spondylitis.
Sharma N; Sharma V; Masood T; Nautiyal SC; Sailwal S; Singh RK; Kushwaha RK; Singh RK
Indian J Clin Biochem; 2013 Apr; 28(2):189-92. PubMed ID: 24426208
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics of Japanese patients with axial spondyloarthritis, and short-term efficacy of adalimumab.
Otsuka A; Morita M; Yamada H
J Orthop Sci; 2015 Nov; 20(6):1070-7. PubMed ID: 26245191
[TBL] [Abstract][Full Text] [Related]
6. Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis.
Jaakkola E; Herzberg I; Laiho K; Barnardo MC; Pointon JJ; Kauppi M; Kaarela K; Tuomilehto-Wolf E; Tuomilehto J; Wordsworth BP; Brown MA
Ann Rheum Dis; 2006 Jun; 65(6):775-80. PubMed ID: 16249228
[TBL] [Abstract][Full Text] [Related]
7. Ankylosing spondylitis and heterogeneity of HLA-B27 in Chinese.
Lin J; Lü H; Feng C
Chin Med J (Engl); 1996 Apr; 109(4):313-6. PubMed ID: 8758295
[TBL] [Abstract][Full Text] [Related]
8. [An HLA-B27 negative case of ankylosing spondylitis with acute iridocyclitis].
Yoshikawa M; Nakamura S; Ohno S
Nippon Ganka Gakkai Zasshi; 1992 Feb; 96(2):271-5. PubMed ID: 1558026
[TBL] [Abstract][Full Text] [Related]
9. Real-world effectiveness and safety of adalimumab for treatment of ankylosing spondylitis in Japan.
Kobayashi S; Kashiwagi T; Kimura J
Mod Rheumatol; 2019 Nov; 29(6):1007-1012. PubMed ID: 30221573
[No Abstract] [Full Text] [Related]
10. Acute anterior uveitis, ankylosing spondylitis, back pain, and HLA-B27.
Beckingsale AB; Davies J; Gibson JM; Rosenthal AR
Br J Ophthalmol; 1984 Oct; 68(10):741-5. PubMed ID: 6236842
[TBL] [Abstract][Full Text] [Related]
11. Association of ORAI1 haplotypes with the risk of HLA-B27 positive ankylosing spondylitis.
Wei JC; Yen JH; Juo SH; Chen WC; Wang YS; Chiu YC; Hsieh TJ; Guo YC; Huang CH; Wong RH; Wang HP; Tsai KL; Wu YC; Chang HW; Hsi E; Chang WP; Chang WC
PLoS One; 2011; 6(6):e20426. PubMed ID: 21674042
[TBL] [Abstract][Full Text] [Related]
12. Influence of HLA-B27 on the Ankylosing Spondylitis phenotype: results from the REGISPONSER database.
Arévalo M; Gratacós Masmitjà J; Moreno M; Calvet J; Orellana C; Ruiz D; Castro C; Carreto P; Larrosa M; Collantes E; Font P;
Arthritis Res Ther; 2018 Oct; 20(1):221. PubMed ID: 30285828
[TBL] [Abstract][Full Text] [Related]
13. [Ankylosing spondylitis (Bechterew) and tissue antigen HLA-B27. III, Heredity of ankylosing spondylitis (Bechterew)].
Gerber N; von Felten A; Böni A; Wagenhäuser F
Z Rheumatol; 1977; 36(7-8):230-8. PubMed ID: 919798
[TBL] [Abstract][Full Text] [Related]
14. Genetic differences between B27 positive patients with ankylosing spondylitis and B27 positive healthy controls.
Calin A; Marder A; Becks E; Burns T
Arthritis Rheum; 1983 Dec; 26(12):1460-4. PubMed ID: 6606431
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of golimumab on recurrent uveitis in HLA-B27-positive ankylosing spondylitis.
Yazgan S; Celik U; Işık M; Yeşil NK; Baki AE; Şahin H; Gencer E; Doğan İ
Int Ophthalmol; 2017 Feb; 37(1):139-145. PubMed ID: 27154720
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the antibody responses to the 77 Klebsiella capsular types in ankylosing spondylitis and various rheumatic diseases.
Sahly H; Kekow J; Podschun R; Schaff M; Gross WL; Ullmann U
Infect Immun; 1994 Nov; 62(11):4838-43. PubMed ID: 7927763
[TBL] [Abstract][Full Text] [Related]
17. Absence of autoantibodies to peptides shared by HLA-B27.5 and Klebsiella pneumoniae nitrogenase in serum samples from HLA-B27 positive patients with ankylosing spondylitis and Reiter's syndrome.
de Vries DD; Dekker-Saeys AJ; Gyodi E; Bohm U; Ivanyi P
Ann Rheum Dis; 1992 Jun; 51(6):783-9. PubMed ID: 1616364
[TBL] [Abstract][Full Text] [Related]
18. HLA B27 and the genetics of ankylosing spondylitis.
Woodrow JC; Eastmond CJ
Ann Rheum Dis; 1978 Dec; 37(6):504-9. PubMed ID: 107868
[TBL] [Abstract][Full Text] [Related]
19. An antiserum to a disease-associated factor from the cells of an HLA-B27 positive patient with ankylosing spondylitis specifically recognizes an HLA-B27 associated determinant.
Sullivan JS; Geczy AF
Arthritis Rheum; 1987 Apr; 30(4):439-42. PubMed ID: 2437933
[TBL] [Abstract][Full Text] [Related]
20. Is there a common pathogenesis in aggressive periodontitis & ankylosing spondylitis in HLA-B27 patient?
Agrawal N; Agarwal K; Varshney A; Agrawal N; Dubey A
Med Hypotheses; 2016 May; 90():63-5. PubMed ID: 27063088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
